BackImmatics N.V - Warrants (01/07/2025) Overview

Immatics N.V - Warrants (01/07/2025) Current Cash

Immatics N.V - Warrants (01/07/2025)'s current cash is $300M.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$301.65M
24.21% YoYΔ $58.80M vs prior year quarter

Peer average

Loading

Immatics N.V - Warrants (01/07/2025) Current Cash History

Loading

Immatics N.V - Warrants (01/07/2025) vs. peers: Current Cash Comparison

Loading

Immatics N.V - Warrants (01/07/2025) Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Immatics N.V - Warrants (01/07/2025) (IMTXW) FAQ

The latest current cash for IMTXW is $300M as of March 2026. That compares with $240M in the prior-year period — up 24.2% year over year. Investors often review this figure alongside Immatics N.V - Warrants (01/07/2025)'s historical trend and sector peers before judging valuation or financial health.

Over the past year, IMTXW's current cash moved from $240M to $300M — a 24.2% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Immatics N.V - Warrants (01/07/2025)'s operating scale or balance-sheet position.

A current cash figure of $300M for IMTXW is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting IMTXW's current cash ($300M), review year-over-year change from $240M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Immatics N.V - Warrants (01/07/2025)'s current cash against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.